Literature DB >> 25604618

Refsum Disease Presenting with a Late-Onset Leukodystrophy.

Flavie Bompaire1, Véronique Marcaud, Emmanuelle Le Trionnaire, Frédéric Sedel, Thierry Levade.   

Abstract

Adult Refsum disease is an autosomal recessive peroxisomal disorder characterized by phytanic acid storage. Clinical symptoms usually begin in late childhood before the age of 20. Typical clinical presentation includes nyctalopia caused by retinitis pigmentosa, and anosmia. After 10-15 years, deafness, cerebellar ataxia, polyneuropathy, ichthyosis, and cardiac arrhythmia can occur.We report the case of a very late-onset adult Refsum disease presenting with marked cognitive decline and severe leukoencephalopathy, without peripheral nervous system involvement. Brain MRI showed a leukoencephalopathy involving the periventricular white matter, subcortical area, and the brainstem with relative sparing of juxtacortical U fibers. This was associated with severe cortical and subcortical atrophy with ventricle dilatation. MR spectroscopy showed a marked increase in the choline/NAA ratio. Elevated plasma phytanic acid level was found, whereas plasma levels of pristanic and very long chain fatty acids were normal. The patient is homozygous for a previously undescribed PHYH frameshift mutation. Whether the very unusual phenotype is related to this peculiar mutation remains unclear.

Entities:  

Year:  2015        PMID: 25604618      PMCID: PMC4501234          DOI: 10.1007/8904_2014_355

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  7 in total

Review 1.  Phytanic acid storage disease (Refsum's disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management.

Authors:  R Weinstein
Journal:  J Clin Apher       Date:  1999       Impact factor: 2.821

2.  Identification of genetic heterogeneity in Refsum's disease.

Authors:  A S Wierzbicki; J Mitchell; M Lambert-Hammill; M Hancock; J Greenwood; M C Sidey; J de Belleroche; F B Gibberd
Journal:  Eur J Hum Genet       Date:  2000-08       Impact factor: 4.246

Review 3.  Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy.

Authors:  Klaus Rüether; Eleanor Baldwin; Minne Casteels; Michael D Feher; Morten Horn; Susan Kuranoff; Bart P Leroy; Ronald J Wanders; Anthony S Wierzbicki
Journal:  Surv Ophthalmol       Date:  2010-09-20       Impact factor: 6.048

Review 4.  Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.

Authors:  Anthony S Wierzbicki; Matthew D Lloyd; Christopher J Schofield; Michael D Feher; F Brian Gibberd
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

Review 5.  Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.

Authors:  R J A Wanders; J C Komen
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

Review 6.  Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7).

Authors:  Gerbert A Jansen; Hans R Waterham; Ronald J A Wanders
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

7.  Identification of PEX7 as the second gene involved in Refsum disease.

Authors:  Daan M van den Brink; Pedro Brites; Janet Haasjes; Anthony S Wierzbicki; John Mitchell; Michelle Lambert-Hamill; Jacqueline de Belleroche; Gerbert A Jansen; Hans R Waterham; Ronald J A Wanders
Journal:  Am J Hum Genet       Date:  2003-01-09       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.